Litigation

Recent Posts

High Court Agrees To Hear Appeal In Securities Suit Against Drug Maker
Posted on 21 Jun 2012 by Timothy Raub

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 11 agreed to hear an appeal of a Ninth Circuit U.S. Court of Appeals ruling affirming a federal district court's grant of class certification in a securities class action lawsuit against... Read More

Tags: George J. Morrow , CRPTF , Securities Exchange Act of 1934 , class action , Kevin W. Sharer , securities litigation , Amgen Inc. , class certification , Connecticut Retirement Plans and Trust Funds , Securities and Exchange Commission Rule 10b-5 , Litigation , lawsuit , Ninth Circuit , Amgen Inc. v. Connecticut Retirement Plans and Trust Funds , securities class action , U.S. Supreme Court , Roger M. Perlmutter , Richard D. Nanula , Securities

Supreme Court Rules Materiality Not A Prerequisite To Certification In Securities Class Action Lawsuit
Posted on 27 Feb 2013 by Timothy Raub

WASHINGTON, D.C. - (Mealey's) Materiality is not a prerequisite to class certification in a securities class action lawsuit where the plaintiffs are seeking monetary damages for alleged violations of Sections 10(b) of the Securities Exchange Act of... Read More

Tags: Epogen , Federal Rule of Civil Procedure 23(b)(3) , George J. Morrow , CRPTF , Roger M. Perlmutter and George J. Morrow v. Connecticut Retirement Plans and Trust Funds , Securities Exchange Act of 1934 , class action , Kevin W. Sharer , securities litigation , Inc. v. Halliburton Co. , Amgen Inc. , class certification , materiality , Connecticut Retirement Plans and Trust Funds , Securities and Exchange Commission Rule 10b-5 , Litigation , Aranesp , Erica P. John Fund , securities class action , U.S. Supreme Court , Roger M. Perlmutter , Basic Inc. v. Levinson , Richard D. Nanula , Securities

California High Court: Pharmacies That 'Passed On' Higher Costs Have UCL Injury
Posted on 12 Jul 2010 by Bryan Redding

SAN FRANCISCO - (Mealey's) Pharmacies have standing to pursue unfair competition law (UCL) claims alleging that they paid higher prices because of price fixing by pharmaceutical companies, even though they passed the higher prices on to consumers... Read More

Tags: pharmacies , Eli Lilly & Co. , Hanover Shoe v. United Shoe Mach , Johnson & Johnson Health Care Systems Inc. , Boehringer Ingelheim Pharmaceuticals , pharmaceutical companies , Pharmaceutical Research and Manufacturers of America , James Clayworth , Abbott Laboratories , Pfizer Inc. , Wyeth Pharmaceuticals , California , UCL , Amgen Inc. , Allergan Inc. , Illinois Brick Co. v. Illinois , Business and Professions Code , price fixing , Cartwright Act , unfair competition law , AstraZeneca International , California Supreme Court , Novartis Pharmaceuticals Corp. , Hoffman-LaRoche Inc. , Litigation , lawsuit , Merck & Co. , Bristol-Myers Squibb Co.

High Court Asked To Decide Whether Securities Suit May Proceed As A Class Action
Posted on 5 Nov 2012 by Timothy Raub

WASHINGTON, D.C. - (Mealey's) A shareholder plaintiff and a pharmaceutical company on Nov. 5 debated in front of the U.S. Supreme Court whether a securities lawsuit may proceed as a class action even if the plaintiff is unable to plead materiality... Read More

Tags: George J. Morrow , CRPTF , class action , Kevin W. Sharer , securities litigation , Litigatin , Amgen Inc. , class certification , Connecticut Retirement Plans and Trust Funds , Amgen Inc. v. Connecticut Retirement Plans and Trust Funds , U.S. Supreme Court , Roger M. Perlmutter , Richard D. Nanula , Securities